164 related articles for article (PubMed ID: 36389115)
1. Network Pharmacology and Molecular Docking Analysis to Explore the Mechanism of Huaiqihuang-Mediated Alleviation of Henoch-Schönlein Purpura Nephritis.
Liu Q; Liu J; Du Y; Guo W; Mi J; Guo Y
Biomed Res Int; 2022; 2022():2798217. PubMed ID: 36389115
[TBL] [Abstract][Full Text] [Related]
2. Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials.
Xue X; Liu XH; Lu CL; Jin XY; Liu Q; Wang XQ; Liu JP
BMC Complement Med Ther; 2021 Nov; 21(1):278. PubMed ID: 34743723
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment.
Wang J; Ma G; Zhang P; Ma C; Shao J; Wang L; Ma C
Medicine (Baltimore); 2023 Dec; 102(50):e36177. PubMed ID: 38115276
[TBL] [Abstract][Full Text] [Related]
4. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
Yu M; Song X; Guo J; Feng Q; Tian J
Eur J Pediatr; 2024 Jul; 183(7):3117-3128. PubMed ID: 38668796
[TBL] [Abstract][Full Text] [Related]
5. Modified Sipjeondaebo-tang (JAROTANG) for Henoch-Schonlein purpura nephritis (HSPN): Two case reports.
Cho S; Jang S; Ryu SS; Park S
Explore (NY); 2023; 19(3):439-444. PubMed ID: 36280432
[TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
[TBL] [Abstract][Full Text] [Related]
7. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
8. [Potential components and mechanism of Liangxue Tuezi Mixture in treating Henoch-Schönlein purpura based on network pharmacology and metabolomics].
Li WX; Xu S; Chen YL; Wang XY; Zhang H; Zhang ML; Ni WJ; Ren XQ; Tang JF
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3327-3344. PubMed ID: 37382017
[TBL] [Abstract][Full Text] [Related]
9. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?
Jelusic M; Sestan M; Cimaz R; Ozen S
Pediatr Rheumatol Online J; 2019 Feb; 17(1):10. PubMed ID: 30819179
[TBL] [Abstract][Full Text] [Related]
10. Effects of dexamethasone and gamma globulin combined with prednisone on the therapeutic effect and immune function of Henoch-Schonlein purpura nephritis in children.
Chen L; Wang X; Yin L; Ma K; Liu X
J Clin Lab Anal; 2021 Jan; 35(1):e23580. PubMed ID: 33174652
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of immune- and apoptosis-related lncRNA-miRNA-mRNA regulatory network in children with Henoch Schönlein purpura nephritis.
Huang L; Li Y; Wang P; Xie Y; Liu F; Mao J; Miao J
Transl Pediatr; 2022 Oct; 11(10):1682-1696. PubMed ID: 36345450
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ quantitative proteomic analysis differentially expressed proteins and signal pathways in henoch-schönlein purpura nephritis.
Gao R; Niu X; Zhu L; Qi R; He L
Am J Transl Res; 2020; 12(12):7908-7922. PubMed ID: 33437369
[TBL] [Abstract][Full Text] [Related]
14. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
15. Use of renin-angiotensin system inhibitors as initial therapy in children with Henoch-Schönlein purpura nephritis of moderate severity.
Nagai S; Horinouchi T; Ninchoji T; Kondo A; Aoto Y; Ishiko S; Sakakibara N; Nagano C; Yamamura T; Kaito H; Tanaka R; Shima Y; Fujimura J; Kamiyoshi N; Ishimori S; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
Pediatr Nephrol; 2022 Aug; 37(8):1845-1853. PubMed ID: 35015121
[TBL] [Abstract][Full Text] [Related]
16. Use of liquid chromatography-tandem mass spectrometry to perform urinary proteomic analysis of children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
Fang X; Lu M; Xia Z; Gao C; Cao Y; Wang R; Wang M; Wu H
J Proteomics; 2021 Jan; 230():103979. PubMed ID: 32932007
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation.
Jin M; Ren W; Zhang W; Liu L; Yin Z; Li D
Drug Des Devel Ther; 2021; 15():4585-4601. PubMed ID: 34785888
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein purpura nephritis in children.
Fu H; Mao J; Xu Y; Gu W; Zhu X; Liu A
Clinics (Sao Paulo); 2016 Sep; 71(9):550-4. PubMed ID: 27652838
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Transcriptomic and Proteomic Analysis Identifies Significant Novel Pathways for Henoch-Schönlein Purpura Nephritis Progression.
Xie B; Zhang W; Zhang Q; Zhang Q; Wang Y; Sun L; Liu M; Zhou P
Biomed Res Int; 2020; 2020():2489175. PubMed ID: 32685455
[TBL] [Abstract][Full Text] [Related]
20. Huanglian Decoction treats Henoch-Schonlein purpura nephritis by inhibiting NF-κB/NLRP3 signaling pathway and reducing renal IgA deposition.
Hu L; Li L; Che H; Zhao B; Xiao LI; Liu P; Yi W; Liu S
An Acad Bras Cienc; 2024; 96(1):e20220970. PubMed ID: 38597498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
